Abionyx Pharma SA (ABNX PA) stock market data APIs
€3.5028
-0.02(-0.6%)
as of May 26, 2026
Try our APIs with
free plan!
Abionyx Pharma SA Financial Data Overview
Price chart is built with
Anychart
ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal, metabolic, and ophthalmic diseases in France and the United States. It operates through Research and Development Activities for the Development of Innovative Drugs; and Contract Research Organization (CRO) Activities segments. The company develops CER-001, a recombinant HDL mimetic biopharmaceutical in a Phase III trial for the treatment of lecithin cholesterol acyltransferase (LCAT) deficiency, as well as in a Phase II trial for the treatment of sepsis. It is also developing ABNX-100, a strategic extension into ophthalmology of CER-001 that is in preclinical trial for the treatment of uveitis. The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was incorporated in 2005 and is headquartered in Balma, France.
Prev. Close
3.5028
Open
3.4831
High
3.5215
Low
3.4286
52 wk Range
1.17-5.29
Market Cap
121 M
Shares Outstanding
35 275 K
Revenue
4 100 K
EPS
0
Beta
0.58
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Abionyx Pharma SA data using free add-ons & libraries
Get Abionyx Pharma SA Fundamental Data
Abionyx Pharma SA Fundamental data includes:
- Net Revenue: 4 100 K
- EBITDA: -5 375 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-25
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Abionyx Pharma SA News
New
3 European Penny Stocks With Market Caps Over €30M To Watch
The European market has recently shown signs of steady economic growth, with major stock indexes rising and the pan-European STOXX Europe 600 Index ending 1.60% higher. This positive momentum, coupled...
European Penny Stocks: 3 Promising Picks With At Least €40M Market Cap
The European stock market has shown resilience amid global trade tensions, with the pan-European STOXX Europe 600 Index ending higher due to hopes for new trade deals, despite recent tariff threats. I...
Pharming Group Announces the Nomination of Barbara Yanni and Mark Pykett to the Board of Supervisory Directors
LEIDEN, Netherlands, May 20, 2020 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) announces the nomination of Barbara Yanni and Mark Pykett to its Board o...
Get Abionyx Pharma SA fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
